Evidera
Dr. Hayley Karn is an accomplished research scientist with extensive experience in patient-centered research, currently employed at Evidera since December 2016. Dr. Karn has authored works for An Appetite for Life and Baby Food Matters and conducted a PhD in behavioural nutrition at University College London, focusing on the relationships between appetite, dietary intake, and weight in young children. With prior roles including qualitative researcher for an NIHR funded project and internships with Danone Nutricia Early Life Nutrition, Dr. Karn has built a solid foundation in evaluating health interventions and contributing to the understanding of nutrition in early life. Academic qualifications include a PhD in Behavioural Nutrition from UCL and a BSc in Psychology from the University of Southampton.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.